Fundraising Fox

Sera Prognostics

NASDAQ: SERA

Salt Lake City, US · Delaware corporation · 7 known investors

Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data. Its products serve pregnant women and their physicians in the maternal-fetal and prenatal diagnostics market.

BiotechDigital HealthFemTechHealthtech

Founders & leadership

DF
Douglas FisherExecutive
JM
Jay MoyesExecutive
GC
Gregory C. CritchfieldExecutive
AA
Andrew A. SauterNamed on SEC filing
RL
Richard L. NovakNamed on SEC filing

Board

MM
Mansoor MirzaBoard director
RM
Ryan M. TrimbleBoard director
JS
Joseph SilettoinBoard Member2021–2021Managing Partner at Vivo Capital
DB
Dennis B. FarrarBoard directorManaging Director at UpStart Ventures
KK
Kim KamdarBoard director
MM
Michael MinahanBoard director
JP
Joshua PhillipsBoard director

Investors · 7

aMoonRa'anana
Excelestar VenturesAndover
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
UpStart VenturesSalt Lake Cityvia Dennis Farrar · board
Vivo CapitalPalo Alto · $10M – $50Mvia Joseph Siletto · board
Catalyst Health VenturesreportedBoston · $1M – $3M
Domain AssociatesreportedPrinceton · $200K – $15M

Reported raises · per SEC filings

Form D private placements

$207.4M disclosed across 8 rounds · 2013–2021

▶$100.3MraisedMay 2021 · 16 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Mansoor MirzaDirector
  • Marcus WilsonDirector
  • Ryan M. TrimbleDirector
  • Joseph SilettoDirector
  • Dennis B. FarrarDirector
  • Douglas FisherExecutive Officer
  • Kim KamdarDirector
  • Michael MinahanDirector
  • Jay MoyesExecutive Officer
  • Joshua PhillipsDirector
  • Gregory C. CritchfieldExecutive Officer, Director
  • Elizabeth CanisDirector
  • Charles KennedyDirector
Offering amount
$100.3M
Amount sold
$100.3M
First sale
Feb 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$51.8MraisedFeb 2020 · 28 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas FisherExecutive Officer
  • Dennis B. FarrarDirector
  • Andrew A. SauterExecutive Officer
  • Gregory C. CritchfieldExecutive Officer, Director
  • Joshua PhillipsDirector
  • Michael MinahanDirector
  • Ryan M. TrimbleDirector
  • Mansoor Raza MirzaDirector
  • Charles D. KennedyDirector
  • Arnold Oronsky, Ph.D.Director
  • Kim KamdarDirector
Offering amount
$53.5M
Amount sold
$51.8M
First sale
Jul 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.4MraisedMar 2019 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Dennis B. FarrarDirector
  • Ryan M. TrimbleDirector
  • Joshua PhillipsDirector
  • Mansoor Raza MirzaDirector
  • Douglas FisherExecutive Officer
  • Arnold Oronsky, Ph.D.Director
  • Andrew A. SauterExecutive Officer
  • Michael MinahanDirector
  • Gregory C. CritchfieldExecutive Officer, Director
  • Kim KamdarDirector
Offering amount
$6.4M
Amount sold
$6.4M
First sale
Feb 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.6MraisedDec 2018 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Arnold Oronsky, Ph.D.Director
  • Michael MinahanDirector
  • Douglas FisherExecutive Officer
  • Joshua PhillipsDirector
  • Mansoor Raza MirzaDirector
  • Dennis B. FarrarDirector
  • Andrew A. SauterExecutive Officer
  • Ryan M. TrimbleDirector
  • Kim KamdarDirector
  • Gregory C. CritchfieldExecutive Officer, Director
Offering amount
$10M
Amount sold
$7.6M
First sale
Nov 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$22.7MraisedJan 2017 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ryan M. TrimbleDirector
  • Kim KamdarDirector
  • Michael MinahanDirector
  • Gregory C. CritchfieldExecutive Officer, Director
  • Joshua PhillipsDirector
  • Douglas FisherExecutive Officer
  • Andrew A. SauterExecutive Officer
  • Dennis B. FarrarDirector
  • Arnold Oronsky, Ph.D.Director
  • Mansoor Raza MirzaDirector
Offering amount
$45M
Amount sold
$22.7M
First sale
Jan 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedNov 2014 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Dennis B. FarrarDirector
  • Douglas FisherDirector
  • Ryan M. TrimbleDirector
  • Andrew A. SauterExecutive Officer
  • Joshua PhillipsDirector
  • Kim KamdarDirector
  • Richard L. NovakDirector
  • Gregory C. CritchfieldExecutive Officer, Director
Offering amount
$25M
Amount sold
$5M
First sale
Nov 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.2MraisedJun 2014 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas FisherDirector
  • Kim KamdarDirector
  • Richard L. NovakDirector
  • Andrew A. SauterExecutive Officer
  • Dennis B. FarrarDirector
  • Ryan M. TrimbleDirector
  • Gregory C. CritchfieldExecutive Officer, Director
  • Joshua PhillipsDirector
Offering amount
$9.2M
Amount sold
$9.2M
First sale
May 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MraisedMar 2014 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew A. SauterExecutive Officer
  • Douglas FisherDirector
  • Richard L. NovakDirector
  • Joshua PhillipsDirector
  • Gregory C. CritchfieldExecutive Officer, Director
  • Ryan M. TrimbleDirector
  • Kim KamdarDirector
  • Dennis B. FarrarDirector
Offering amount
$4.5M
Amount sold
$4.5M
First sale
Sep 2013
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap
Seeking Alpha10 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Public9 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
StockTwits7 shared keywordsStocktwits is a social platform for investors and traders to share market news, discussions, sentiment polls, and live financial content. It aggregates breaking market news, equity coverage, and community discussions around individual stocks and crypto.
Robinhood7 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
TradingView6 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.

Companies competing with Sera Prognostics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Sera Prognostics Still Needs Revenue Proof to Match Its Clinical Momentum - Alphastreetnews.alphastreet.com · Aug 2026Sera Prognostics names Scott Gleason as chief financial officer By Investing.comca.investing.com · Aug 2026SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICERprnewswire.com · Aug 2026Sera Prognostics Q2 Financial Results: $30K Revenue | SERA Stock Newsstocktitan.net · Aug 2026SERA PROGNOSTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTStucson.com · Aug 2026Sera Prognostics Raises $19.3M in Series A Funding - FinSMEsfinsmes.com · Nov 2011

Frequently asked questions

What does Sera Prognostics do?
Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data. Its products serve pregnant women and their physicians in the maternal-fetal and prenatal diagnostics market.
Who are Sera Prognostics's investors?
Sera Prognostics's investors include aMoon, Excelestar Ventures, OUP (Osage University Partners), UpStart Ventures, Vivo Capital, Catalyst Health Ventures, Domain Associates.
How much funding has Sera Prognostics raised?
Sera Prognostics has disclosed $207.4M raised across 8 rounds.
Where is Sera Prognostics headquartered?
Sera Prognostics is headquartered in Salt Lake City, US.